Gilead Sciences shares are trading around 10% lower hovering around $41 after the company issued weaker-than-expected 2010 guidance.The company lowered its 2010 sales forecast by about $200 million to a range of $7.4 billion to $7.5 billion due to the impact of the recently passed health care reform.
Wednesday, April 21, 2010
Gilead Falls 10% due to Lower Forecasts
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment